Brez internetne povezave — prikazana je shranjena različica strani.

Novo Nordisk A/S

DEEUR
← Na Filter Delnic

Novo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

⚠ Ne zamenjujte: obstaja še eno podjetje z enakim ali zelo podobnim imenom. To je ločen zapis — preverite ticker, borzo in registrsko številko.

O Podjetju

Spletna Stran
novonordisk.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
BAGSVAERD DENMARK, Denmark
Izvršni Direktor
Maziar Mike Doustdar
Zaposleni
66 700
Delnice v Obtoku
3.34 mrd.
Prosto Prenosljive Delnice
3.17 mrd.
Tržna Kapitalizacija
150.93 mrd. EUR
Notranje Osebe
5.27%
Institucionalni Vlagatelji
33.78%
Panoga (SIC)
Pharmaceutical Preparations
Pravna Oblika
ZRPO
ISIN
DK0060534915
LEI
549300DAQ1CVT6CXN342
Delež Izplačila
50.5%
FCF
59.0 mrd. DKK
Izplačilo / FCF
88%
Dolg
143 mrd. DKK
2.0 let FCF
Dividendni Staž
24 let
Dobički, FCF in izplačane dividende — za 12 mesecev do 31.12.2025 (najnovejše poročilo podjetja).
Opis

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
XETRA XetraNOV glavnaEUR33.21 +0.00%navadne delnice
LSE London Stock Exchange0QIU IOBGBP257.55 +1.45%navadne delnice
US USA StocksNONOF OTCUSD38.84 -1.61%navadne delnice

Cena v 5 letih (tedenske sveče)

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Na leto, US:NONOF: 11.7 DKK (2 izpl.)

Novo Nordisk A/S (NONOF) izplačuje dividende dvakrat letno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 11.7 DKK na delnico (plačila: 2). Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 15.02.2027. Leta neprekinjenih dividend: 24.

Ex-DatumIzplačiloZnesek%VrstaOznaka
2026-08-172026-08-183.7500 DKK1.2/3.9 %polletnoUS:NONOF
2026-03-302026-03-317.9500 DKK3.4/5.0 %polletnoUS:NONOF
2025-08-182025-08-193.7500 DKK1.1/3.4 %polletnoUS:NONOF
2025-03-312025-04-017.9000 DKK1.7/2.5 %polletnoUS:NONOF
2024-08-162024-08-193.5000 DKK1.4/3.8 %polletnoUS:NONOF
2024-03-222024-03-266.4000 DKK2.5/≈5.0 %polletnoUS:NONOF

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
VANGUARD STAR FUNDS-Vang…1.38%46.88 mio.2026-07-31
EuroPacific Growth Fund-…1.07%36.2 mio.2026-06-30
VANGUARD TAX-MANAGED FUN…0.92%31.13 mio.2026-06-30
Capital World Growth & I…0.77%26.02 mio.2026-06-30
iShares Trust-iShares Co…0.71%24.13 mio.2026-08-31
Income Fund of America0.52%17.78 mio.2026-07-31
Dodge & Cox Funds-Dodge…0.39%13.1 mio.2026-06-30
Fidelity Concord Street…0.37%12.52 mio.2026-07-31
iShares Trust-iShares MS…0.34%11.48 mio.2026-08-31
Capital Income Builder0.3%10.32 mio.2026-07-31
Cygnus Capital Advisors,…0%78 8002026-06-30
Generali Investments Cee…0%27 3992026-06-30
Pacer Advisors, Inc.0%24 4102026-06-30
Atlas Capital Advisors I…0%5 2182026-06-30
Novo Holdings———
Novo Nordisk Foundation———